Table 2.
Low-risk cohort (n=359) |
High-risk cohort (n=400) |
|
n (%) | n(%) | |
No/indeterminate ISS* | 90 (25) | 121 (30.2) |
Isolated ISS† | ||
P1 | 1 (0.4) | 8‡ (2.9) |
P2 | 40 (14.8) | 37 (13.3) |
P3 | 42 (15.6) | 16‡ (5.8) |
P1/P2 | 6 (2.2) | 13 (4.7) |
P2/P3 | 136 (50.6) | 142 (51) |
>1 ISS† | ||
Double ISS | 37 (13.8) | 55 (19.8) |
Treble ISS | 7 (2.6) | 6 (2.2) |
Quadruple ISS | 0 (0) | 1 (0.3) |
Total | 269 (100) | 278 (100) |
*Calculated as a percentage of the entire cohort.
†Calculated as a percentage of cases with identifiable ISS of the posterior mitral valve leaflet.
‡P<0.05.